Clinical practice guidelines on the assessment and management of cognitive impairment in major depressive disorder
Om Prakash Singh,
Priya Ranjan Avinash,
Anita Gautam
и другие.
Indian Journal of Psychiatry,
Год журнала:
2025,
Номер
67(1), С. 98 - 105
Опубликована: Янв. 1, 2025
INTRODUCTION
Epidemiology
Cognitive
deficit
is
a
trivialized
symptom
of
most
prevalent
psychiatric
condition
called
major
depressive
disorder
(MDD).[1]
With
staggering
global
prevalence
approximately
350
million,
MDD
contributes
to
significant
loss
in
quality
life
and
increased
economic
burden.[2]
One
or
more
cognitive
faculties
patients
are
adversely
affected
tend
persist
despite
the
remission
episode
[Figure
1].[3]Figure
1:
Concise
framework
assessment
management
Cognition
Subjects
with
Major
Depressive
DisorderUpon
resolution
episode,
individual
may
show
experience
considerable
improvement
measures.
but
there
still
residual
symptoms
that
continue
exist.
[Table
1].[4]
The
one
has
been
reported
be
standard
deviations
below
normative
value,
25–50%
subjects
MDD.[4]Table
domains
disorderCognitive
disorder:
an
epiphenomenon
endophenotype
Recent
research
suggests
impairment
depression
accurately
conceptualized
as
rather
than
merely
epiphenomenon.
As
endophenotype,
represent
heritable
trait
increases
vulnerability
persists
even
during
periods
remission.[5]
presence
this
create
"double
hit"
effect,
where
underlying
interacts
neurotoxic
effects
episodes,
potentially
accelerating
neurodegeneration
increasing
risk
developing
conditions
such
mild
(MCI)
dementia.
This
interplay
between
deficits
vicious
cycle,
each
exacerbating
other
over
time,
ultimately
leading
profound
persistent
neurocognitive
impairments.[6]
Aside
from
continuum,
lies
pseudodementia.
reversible
dementia-like
phenomenon
appears
mood-cognition
medius.
Table
2
gives
concise
comparison
phenotypes
associated
different
conditions.
mood
cognition
further
gets
complicated
when
iatrogenic
factor
takes
wheel.
mechanisms
how
psychotropics
lead
deterioration
have
presented
3.[7]Table
2:
Comparison
disorders
lying
on
spectrumTable
3:
Mechanisms
psychotropic
induced
impairmentDissecting
mdd
phenotypic
definition
DSM5
(Diagnostic
Statistical
Manual
5)
typology
for
includes
discrete
clinical
as:
melancholia,
anxious
distress,
atypicality,
psychotic
features
mixed
features,
those
peripartum
onset.
Williams
et
al.
2013,
took
neural
circuitry-based
approach
define
biotypes
4].[13]Table
4:
Different
Biotypes
Depression
based
circuitryAgainst
prevailing
belief,
problems
would
automatically
improve
got
better,
mediation
models
improvements
control
directly
influence
reduction
enhancement
after
treatment.[4]
Course
across
various
Previously
we
discussed
involvement
several
1]
MDD.
However,
heterogeneity
functioning
points
course
independent
treatment[14]Table
5
summarizes
longitudinal
change
domains.Table
5:
temporal
evolution
MDDNeurobiological
underpinnings
multisystem
aberrancy
starting
at
level
genetic
architecture
evolving
into
myriad
cascades.
Various
chronic
proinflammatory
neuroimmune
axis
alterations,
advent
any
stressor,
translate
changes
neurochemistry
brain
connectivity.
leads
shift
"rational
brain"
towards
"emotional/sensory
brain."
processing
negative
stimuli.[17]
Predictors
outcome
line
evidence
regarding
outcomes
limited
often
mixed.
While
plethora
studies
incredible,
duration
investigating
demographic
age-related
variables
was
short.
6
findings
respective
reviews
predictors.[18,19]Table
6:
good
poor
MDDThe
existing
qualitative
patient-related
measures
held
priority
by
large
number
mental
healthcare
professionals.[20]
guideline
aims
provide
evidence-based
recommendations
individuals
disorders.
OBJECTIVES
To
standardize
disorder.
once
they
achieve
remission.
outline
strategies
persisting
achieved
enhance
awareness
understanding
among
end
users
i.e.,
Psychiatrists
health
professionals.
SCOPE
intended
use
psychiatrists,
psychologists,
professionals
involved
care
ASSESSMENT
OF
COGNITIVE
IMPAIRMENT
General
evaluation
1]:Any
setting
undergoes
preliminary
which
screens
them
psychopathology,
its
severity.
presentation
should
fulfill
ICD
10
DSM
criteria,
required
reach
diagnosis
Neither
these
classifications
mentions
dysfunction
phenotype.
These
guidelines
used
conjunction
Clinical
Practice
Guidelines
issued
Indian
Psychiatry
Society
general
elderly
population.[21,22]Evaluation
features:
A
baseline
entails
ruling
out
illnesses.
itself
not
primary
pathology.
Hence
while
it
relevant
exclusive
same,
empirical
cognizant
might
predictive
prognostic
marker
treatment
functioning.
widely
scales
HAM-D
21
MADRS
items
assessing
symptomatology.
insufficient
information.
Several
screening
tools
validated
indian
population
listed
7].
For
comprehensive
evaluation,
prominent
institutional
bodies
constructed
application
8].Table
7:
Screening
cognitionTable
8:
tests
standardized
populationCommon
neuropsychological
tests:
Trail-making
test
Digit
span
Controlled
oral
word
association
Token
Test
Stroop
Rey
Complex
figure
Wisconsin
Card
Symbol
digit
modalities
symbol
substitution
test:
California
Verbal
Learning
Test/Ray
auditory
Clock
drawing
Weschler
Adult
Intelligence
Scale
4th
edition
(WAIS-IV)
adaptation
Other
Not
India
yet
Perceived
Deficits
Questionnaire-Depression
(PDQ-D)
20:
subjective
4
cognition,
namely:
attention/concentration,
retrospective
memory,
prospective
planning/organization.[3]
Online
computerized
tests[3]:
THINC-it®
resource
CANTAB:
Cambridge
Neuropsychological
Automated
Battery
(CANTAB)
computer-based
system.
MANAGEMENT
There
no
way
addressing
challenges
impairments
In
cognizance
studied.
2].Figure
Modalities
crucial
elements
influencing
outcomesA.
Stand-alone
adjunctive
pharmacotherapy
AntidepressantsThere
randomized
controlled
trials
(RCTs)
NMAs
comparing
effect
wide
range
antidepressants
9.
Only
Shilyansky
2016[24]
Prado
2018[23],
meta-analyses
study
focused
conventional
antidepressants.
rest
included
multimodal
agent
Vortioxetine.
three
studies,
Vortioxetine
consistently
outperformed
common
terms
benefits.[26–29]Table
9:
NMA
(Network
Meta
Analyses)
describing
outcomes.Adjunctive
atypical
antipsychoticsThere
only
showed
beneficial
results
executive
continuous
attention
cognition.
favoring
addition
aripiprazole
antidepressants.[30]
likely
indirect
stabilizing
mood.[31]Non-conventional
Drug
therapies
Ketamine/Eketamine
modulates
glutamate
neurotransmission,
can
rapid
antidepressant
procognitive
effects.[14–16]
Concerns
raised
long-term
modulator
MDD.[32]
Cholinesterase
inhibitors,
donepezil
galantamine,
shown
their
inhibitors
found
ameliorate
subsyndromal
dementia
behavioral
symptoms.
function
older
adults
inconsistent[33,34]
Eugeroics:
agents
promote
wakefulness
modulating
dopamine
neurotransmitters.
Few
modafinil
armodafinil
depression,
reduce
fatigue,
cognition.[34,35]
Memantine,
NMDAR
antagonist,
well
established.
RCT
assessed
efficacy
adjunct
memantine
old
delayed
recall
group.[23]
Psychological
treatments
Remediation
Therapy
(CRT)
intervention
designed
Components:
Computerized
Exercises:
Patients
engage
structured
tasks
challenge
processes.
Strategy
Training:
Participants
learn
compensatory
manage
difficulties.
Group
Sessions:
CRT
involves
group-based
training
foster
social
interaction
support.
tailored
person's
specific
needs.
It
combined
(e.g.,
psychotherapy,
pharmacotherapy)
treatment.[36]
behavior
(CBT):In
meta-analysis
Cristea
(2015),
CBT
robust
medium
improving
dysfunctional
thinking
depression.
Its
ability
restructuring
activation
available
evidence.
were
differences
thoughts.
More
needed
fully
understand
differential
psychotherapies
depression.[37,38]Other
Psychotherapies:
less
extensive
data
psychological
outcomes.
Neurostimulation
Transcranial
Magnetic
Stimulation
(TMS):
Individual
report
however
montage
used,
stimulation
intensity,
pulse
pattern.[39,40]
practice
therapeutic
response
rTMS
neuropsychiatric
mention
supporting
role
relative
outcome.[41]
systematic
review
58
faculties.[42]
direct
current
(tDCS):
Anodal
tDCS
usually
applied
left
dorsolateral
prefrontal
cortex
(DLPFC).
Direct
Current
(tDCS)
promising
case-control
conducted
depressed
patients.
ELECT-TDCS,
SELECT-TDCS,
DepressionDC
trial
did
corroborate
findings.[43]
Electroconvulsive
(ECT):
therapy
(ECT)
acute,
short-term,
functions
speed,
function,
attention.[44]
Studies
suggest
ECT
achieving
memory
verbal
recall.[45]
important
note
vary
factors
age,
premorbid
intellectual
gender,
anesthetic
technique
used.[46]
Therefore,
alternate
neurostimulation
method
recommended
better
outcomes[47]
Vagus
Nerve
(VNS)
Figure
3
illustrates
bottom-up
mechanism
vagus-mediated
enhancement.
Through
preclinical
study,
vagus
nerve
efficacious
paired
learning
consolidation
phase
task.Figure
Mechanism
enhancementThere
also
superior
transcutaneous
Cervical
VNS
auricular
VNS.
Two
open
demonstrated
diagnosed
treatment-resistant
depression.[48,49]
within
month,
gradual
improvement.
sustained
12
months[48]
Complementary
Alternative
medical
(CAMTs):
defined
"a
group
diverse
systems,
practices,
products
generally
considered
part
medicine."
Mind–Body
MedicineMindfulness-based
stress
(MBSR)
mindfulness-based
(MBCT)
body
at-least
domain
least
symptomatology.[50]
methodology
inspecting
uniform.
Additionally,
requires
properly
trained
instructors
administer
treatment.Aerobic
ExerciseA
overall
use.
concluded
optimal
exercise
parameters
moderate-to-vigorous
times
per
week,
session
60
minutes,
weeks
less,
complementary
effective
works
especially
medication
inpatient
settings.[51]Natural
ProbioticsA
2019
performance
psychobiotic
Lactobacillus
Plantarum
299v
(LP299v)
aligned
decrease
serum
kynurenine
levels.[52]
improved
episodic
high
doses
probiotics.[53]Nootropics:
Recombinant
erythropoietin
(EPO):
double-blind,
randomized,
placebo-controlled,
recombinant
mood-independent
manner.[27]
potential
novel
nootropics:
nootropics
limited.
Well-designed,
large-scale
RCTs
investigate
safety.
describe
benefits.[54]
Minocycline
Insulin
Antidiabetic
Agents
Thiazolidinediones).
S-Adenosyl
Methionine
(SAMe)
Omega-3
Polyunsaturated
Fatty
Acids
N-acetylcysteine
(NAC)
Curcumin
Statins
Coenzyme
Q10
Gingko
biloba
extract
EGb761.[55]
rehabilitation:
MDD,
flexibility
performing
goal-directed
activity.
rehabilitation
employs
repetitive
like
working
causing
disrupted
circuitry.[56]
2016
moderate
size
attention,
Memory.
two
types:
Strategy-based
training:
Personalising
target
faculty,
example,
inductive
reasoning.[57]
Process-based
programmed
entrain
participant
hierarchy
cumulatively
process.
speed
attentional
breadth
Task-switching
training.[57]
tasks:
commonly
Paced
Auditory
Serial
Addition
(PASAT),
skills
measuring
PASAT
abilities,
Sommer
al.,
metacognitive
skills,
maladaptive
thought
patterns
(i.e.,
rumination),
Moreover,
Computer-based,
arithmetic
exercises,
focus
sequencing,
intelligence
quotient
(IQ),
increase
psychosocial
functioning,
hippocampal
frontotemporal
MDD.[56]
CONCLUSION
much
previously
thought.
observed
both
symptomatic
recovery
phases
multidomain
some
being
vulnerable
others.
Early
detection
watchful
prompt
all
Based
resources
needs
patient
tailor-made
include
repeated
detailed
assessment.
pharmacotherapy,
alternative
lifestyle
management,
neuromodulation
combination
resources.
Financial
support
sponsorship
Nil.
Conflicts
interest
conflicts
interest.
Язык: Английский
Beurteilung kognitiver Funktionen
Ralf Dohrenbusch,
Alina Seidel
Springer eBooks,
Год журнала:
2025,
Номер
unknown, С. 1007 - 1023
Опубликована: Янв. 1, 2025
Neurostructural changes in schizophrenia and treatment-resistance: a narrative review
Deleted Journal,
Год журнала:
2024,
Номер
4
Опубликована: Янв. 1, 2024
Abstract
Schizophrenia
is
a
complex
disorder
characterized
by
multiple
neurochemical
abnormalities
and
structural
changes
in
the
brain.
These
may
begin
before
recognizable
clinical
symptoms
appear
continue
as
dynamic
process
throughout
illness.
Recent
advances
imaging
techniques
have
significantly
enriched
our
comprehension
of
these
alterations,
particularly
focusing
on
gray
white
matter
irregularities
prefrontal,
temporal,
cingulate
cortex
alterations.
Some
suggest
treatment
resistance
to
antipsychotic
medications,
while
nonadherence
relapses
further
exacerbate
abnormalities.
This
narrative
review
aims
discuss
literature
about
alterations
deficits
within
brain,
which
could
improve
understanding
schizophrenia
how
interpret
neurostructural
changes.
Язык: Английский
Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
Psychiatry Research,
Год журнала:
2024,
Номер
unknown, С. 116272 - 116272
Опубликована: Ноя. 1, 2024
Язык: Английский
Beurteilung kognitiver Funktionen
Ralf Dohrenbusch,
Alina Seidel
Springer eBooks,
Год журнала:
2024,
Номер
unknown, С. 1 - 17
Опубликована: Янв. 1, 2024
Blood metabolites, neurocognition and psychiatric disorders: a Mendelian randomization analysis to investigate causal pathways
Translational Psychiatry,
Год журнала:
2024,
Номер
14(1)
Опубликована: Сен. 16, 2024
Neurocognitive
dysfunction
is
observationally
associated
with
the
risk
of
psychiatric
disorders.
Blood
metabolites,
which
are
readily
accessible,
may
become
highly
promising
biomarkers
for
brain
However,
causal
role
blood
metabolites
in
neurocognitive
function,
and
biological
pathways
underlying
their
association
disorders
remain
unclear.
Язык: Английский
Iowa Gambling Task performance in individuals with schizophrenia: the role of general versus specific cognitive abilities
Frontiers in Psychiatry,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 10, 2024
Objective
We
aimed
to
explore
how
specific
cognitive
processes,
such
as
attention
and
executive
functions,
account
for
variance
in
decision-making
measured
by
Iowa
Gambling
Task
(IGT)
performance
among
individuals
with
schizophrenia
spectrum
disorders.
Methods
Adults
(
N
=
65,
M
age
25.4)
disorders
participating
a
clinical
trial
(registered
at
clinicaltrials.gov
NCT03048695)
completed
the
IGT,
neuropsychological
tests
of
attention,
response
inhibition,
mental
flexibility,
working
memory,
planning,
well
subtests
from
Wechsler
intelligence
estimate
IQ.
Associations
between
on
tasks,
composite
score
function
IGT
two
ways,
one
using
total
net
score,
decks
(C+D)
–
(A+B)
other
preference
more
frequent
gains
than
losses,
(B+D)
(A+C),
were
analyzed
correlational
hierarchical
regression
analysis
controlling
estimated
IQ
psychotic
symptoms,
Positive
Negative
Syndrome
Scale.
Results
In
analyses,
strongest
predictor
was
b
1.43,
p
<.001).
Neither
tasks
nor
functioning
significantly
contributed
explaining
beyond
symptoms
psychosis.
However,
psychosis
did
not
predict
tendency
towards
selecting
different
gain-to-loss
frequency,
whereas
poorer
predicted
pattern
A
C
8.30,
<.05).
Discussion
The
results
suggest
that
both
functions
contribute
performance,
but
distinct
ways.
Whereas
lower
may
overall
disadvantageous
decision-making,
risk-aversive
style.
implication
be
or
will
have
higher
need
support
interventions
targeting
decision-making.
Язык: Английский